- Home
- MGRX vs HBIO Comparison
MGRX vs HBIO Comparison
Compare MGRX & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGRX
- HBIO
- Stock Information
- Founded
- MGRX 2021
- HBIO 1901
- Country
- MGRX United States
- HBIO United States
- Employees
- MGRX N/A
- HBIO N/A
- Industry
- MGRX Computer Software: Prepackaged Software
- HBIO Biotechnology: Laboratory Analytical Instruments
- Sector
- MGRX Technology
- HBIO Industrials
- Exchange
- MGRX Nasdaq
- HBIO Nasdaq
- Market Cap
- MGRX 25.2M
- HBIO 24.6M
- IPO Year
- MGRX 2023
- HBIO 2000
- Fundamental
- Price
- MGRX $2.62
- HBIO $0.42
- Analyst Decision
- MGRX
- HBIO Buy
- Analyst Count
- MGRX 0
- HBIO 3
- Target Price
- MGRX N/A
- HBIO $2.50
- AVG Volume (30 Days)
- MGRX 217.2K
- HBIO 553.3K
- Earning Date
- MGRX 11-13-2025
- HBIO 11-06-2025
- Dividend Yield
- MGRX N/A
- HBIO N/A
- EPS Growth
- MGRX N/A
- HBIO N/A
- EPS
- MGRX N/A
- HBIO N/A
- Revenue
- MGRX $516,030.00
- HBIO $88,750,000.00
- Revenue This Year
- MGRX N/A
- HBIO N/A
- Revenue Next Year
- MGRX N/A
- HBIO $7.02
- P/E Ratio
- MGRX N/A
- HBIO N/A
- Revenue Growth
- MGRX N/A
- HBIO N/A
- 52 Week Low
- MGRX $1.32
- HBIO $0.28
- 52 Week High
- MGRX $6.15
- HBIO $2.82
- Technical
- Relative Strength Index (RSI)
- MGRX 59.26
- HBIO 39.39
- Support Level
- MGRX $2.08
- HBIO $0.41
- Resistance Level
- MGRX $2.61
- HBIO $0.45
- Average True Range (ATR)
- MGRX 0.25
- HBIO 0.02
- MACD
- MGRX 0.01
- HBIO -0.00
- Stochastic Oscillator
- MGRX 91.65
- HBIO 13.20
About MGRX Mangoceuticals Inc.
Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The company's platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products.
About HBIO Harvard Bioscience Inc.
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, pharmaceutical and therapy discovery, bioproduction, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, and Panlab. The majority of its revenue comes from the United States.